Metabolic associated fatty liver disease
Fatty Liver Breakthrough: Vitamin B3 Shows Promise
Approximately 30 percent of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that previously lacked targeted treatments. In a groundbreaking discovery, researchers have identified a genetic factor that exacerbates the disease, and remarkably, the FDA-approved drug that most effectively targets this factor is vitamin B3. A collaborative research team led ...
Aerobic Exercise Could Have the Final Say on Fatty Livers
A new study from Trinity College Dublin (Ireland) highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver diseases during exercise trials, rather than weight loss. The findings have been published in the medical journal Alimentary Pharmacology and Therapeutics. Metabolic associated fatty liver disease (MAFLD) is a condition characterized ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
